Simvastatin-induced dermatomyositis;Simvastatin-induzierte dermatomyositis

Hautarzt

Volumn 60, Issue 6, 2009, Pages 489-493

  Rasch, A ^a   Schimmer, M ^a   Sander, C A ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

Dermatomyositis; HMG CoA reductase inhibitors; Polymyositis; Simvastatin

Indexed keywords

ANTIBODY; AZATHIOPRINE; LEVOTHYROXINE; MI 2 ANTIBODY; PREDNISOLONE; SIMVASTATIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; BACKACHE; CASE REPORT; DERMATOMYOSITIS; DRUG INDUCED DISEASE; EXHAUSTION; FEMALE; HEAT INTOLERANCE; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPOTHYROIDISM; MUSCLE WEAKNESS; OUTCOME ASSESSMENT;

AGED; ANTICHOLESTEREMIC AGENTS; DERMATOMYOSITIS; FEMALE; HUMANS; SIMVASTATIN;

EID: 67649949086     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-008-1637-5     Document Type: Article

References (12)

1. Choy EH, Hoogendijk JE, Lecky B, Winer JB (2005) Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev 20; CD003643
2. Dalakas 1993 New Engl J Med 329 1993
3. Fauchais 2004 Rev Med Interne 25 294
4. Lawrence 2002 Expert Opin Pharmacother 3 1631
5. Owczarek 2005 Pharmacol Rep 57 23
6. Köller 2005 Nervenarzt 76 212
7. Sieb 2003 Muscle Nerve 27 142
8. Stertz G (1916) Polymyositis. Berlin, Klin Wochenschr 54: 489
9. Thual 2005 Ann Dermatol Venereol 132 996
10. Vasconcelos 2004 Muscle Nerve 30 803
11. Zuech 2005 Rev Med Interne 26 897
12. Noël 2004 Dermatology 208 276